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ABSTRACT
Objective: This study aims to determine the condition of the hemoglobin (Hb) level after the initial phase of antitubercular drug usage.
Methods: This research method used a descriptive survey design with the accidental sampling method. The sample of this study was 38 patients who 
met the inclusion criteria of the study. The sample was measured by Coulter Act-Diff Hematology Analyzer.
Results: This study shows the initial phase of antitubercular drugs (ATD) usage caused an abnormal hemoglobin level of 22 patients (58%) and 
16 patients (42%) have a normal level. There are 12 (32%) male and 10 (26%) female patients have an abnormal level of Hb. The average of Hb level 
in tuberculosis (TB) patients is 12.42 (male) and 11.89 (female). This study also shows the correlation between body mass index with a Hb level of 
TB patient (p=0.001).
Conclusion: Hb levels in TB patients who consumed the initial phase of ATD were found to be mostly under normal.
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INTRODUCTION
Tuberculosis (TB) is an infectious disease caused by Mycobacterium 
TB. TB is one of the top 10 causes of death and the leading cause of a 
single infectious agent. In 2017, TB causes an estimated of 1, 3 million 
deaths among HIV-positive people. There were cases in all countries 
and age groups, but overall 90% were adults (aged ≥15 years), 9% were 
people living with HIV (72% in Africa), and two-thirds were in eight 
countries: India (27%), China (9%), Indonesia (8%), the Philippines 
(6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%), and South Africa 
(3%) [1]. Current therapy management of TB is inadequate due to the 
lengthy course of treatment, drug-related side effects and ill-planned 
therapy [2]. Many research related to the medicinal properties of the 
plants, when researched through modern scientific methods, may 
prove to have enormous potential in the discovery of newer and more 
efficacious antitubercular medicines [3].
The spread of pulmonary TB from one patient to another occurs 
through the infectious air that can come out with coughing, sneezing, 
and talking [4]. The source of infection is the lung TB patients who 
cough sputum, where the sputum smear examination is generally 
found positive acid-fast bacilli. An intensive 2-month initial phase of TB 
treatment was performed by administering antitubercular drugs (ATD) 
consisting of isoniazid, pyrazinamide, rifampicin, and ethambutol [5]. 
The hematologic examination includes hemoglobin (Hb), leukocyte 
count, erythrocyte count, platelet count, hematocrit, and blood capillary 
examination may be indicative of complications or an ATD complication.
Anemia is a major feature in patients with bacterial infections, especially 
infections that last >1 month. In pulmonary, TB patients increased Hb 
level is used as a marker of treatment response [6]. This research aims 
to determine the condition of Hb level after the initial phase of ATD 
usage in TB patients.
METHODS
This research was conducted with an accidental sampling method at 
pulmonary polyclinic RSUD Dr. M. Yunus Bengkulu in December 2017–
June 2018. The sample of this study consisted of 38 TB patients after the 
initial phase of ATD usage. Before taking 3 ml blood samples, provided 
the patient informed consent. The sample was measured by Coulter 
Act-Diff Hematology Analyzer.
RESULTS AND DISCUSSION
Based on research that has been done in hospitals Dr. M. Yunus Bengkulu 
in 2018, Hb level was obtained in TB patients after taking the ATD in the 
initial phase which showed that from 38 patients with were 22 patients 
(58%) of who had below normal Hb level and 16 people (42%) have 
normal Hb levels. The Hb levels of respondents below normal are caused 
by infection TB and side effects of ATD especially rifampicin, isoniazid, 
and pyrazinamide that can cause anemia hemolytic nausea, vomiting, 
and no appetite [7]. The treatment of choice for the initial phase is 
the daily use of isoniazid, rifampicin, pyrazinamide, and ethambutol. 
The combination of ATD during an initial phase is designed to reduce 
the bacteria population rapidly and to prevent the drug-resistant 
bacteria [5]. Many studies about the effect of antitubercular drugs to Hb 
level have done in Indonesia and they have the same result, there is the 
Hb level decrease after antitubercular drugs usage [2,6,7].
The results of this study showed that patients with TB who had under-
normal Hb level in the elderly 46–55 years old as many as 10 patients 
(26%) and the final age of 56–65 years as many as 5 patients (13%), 
this is due to the side effects of ATD the initial phase consumed daily. 
Research conducted in Korea on TB patients showed results from 880 
TB patients, 281 (31.9%) showed symptoms of anemia. Anemia is also 
common in women and older age [10]. At the age of the elderly life 
cycle is characterized by the decline in the various functions of organs, 
which is characterized by the more vulnerable the body against various 
attacks of disease. This is due to the increasing age that changes in the 
structure and function of cells, tissues, and organs.
Body mass index (BMI) is a simple measuring instrument to monitor 
nutritional status [11]. Nutritional status has a correlation positive with 
Hb concentration, meaning that a person’s nutritional status is getting 
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worse than the lower the Hb level of the person [12]. From the research 
data, TB patients with BMI <18 all had abnormal Hb levels of 11 (100%) 
patients, whereas patients with BMI 18–25 had 11 (40.7%) patients 
who had abnormal Hb levels and in this study found the correlation Hb 
level with intima-media thickness (p=0.001). Hemoglobin levels of TB 
patients below normal are due to malnutrition especially iron which is 
part of the Hb molecule. Reduced iron can lead to reduced hemoglobin 
synthesis resulting in lower hemoglobin levels. Things that can reduce 
the occurrence of Hb levels below normal values are by way of initial 
phase TB patients consuming foods containing iron such as red meat, 
egg yolks, fish, vegetables (spinach, cassava leaves, kale, and mustard), 
and soybeans [12].
CONCLUSION
Hb levels in TB patients who consumed the initial phase of ATD were 
found to be mostly under normal.
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